Home > Healthcare & Medical Devices > Vocal Biomarkers Market
Vocal Biomarkers Market size is slated to record significant gains through the coming years. This can be ascribed to the rising prevalence of neurological, psychological, and other speech-related diseases, including attention deficit, Parkinson’s disease, depression, and cardiovascular diseases. These diseases need less invasive diagnostics for the treatment, thus producing a demand spurt for vocal biomarkers.
Vocal biomarkers are generally used to detect illnesses using speech features in a non-invasive way. Its application is based on the idea that severe ailments impact motor control and hence modify speech output by affecting speech features.
The market is further propelled by expanding research on vocal biomarkers. Citing an example, Mayo Clinic, had in 2020 announced collaborating with Vocalis Health to research and develop new voice-based tools for detecting, screening, and monitoring patient health. This would support the detection of pulmonary hypertension in people.
However, increased prices of invasive procedures are expected to emerge as a significant challenge for the overall growth of vocal biomarkers market.
Vocal tremor segment is projected to observe considerable growth over the forecast period of 2021-2027. It is a neurological disorder that causes involuntary movement of muscles in the throat as well as in vocal cords. Moreover, increasing prevalence of neurological disorders and expanding application of vocal tremors in neurological disorder would further stimulate the market dynamics.
Vocal biomarkers are being massively used for detecting neurological conditions. Ailments like Alzheimer’s, Schizophrenia, and Parkinson generally come to light at a later stage of the disease, restricting the doctor’s ability to adopt stringent measures. This enables players in the pharmaceutical industry to develop and work on vocal biomarkers to support early diagnosis of such conditions. Besides healthcare, vocal biomarkers also find applications in lie detection. They are deemed to be useful in defense organizations and security agencies while questioning a criminal.
Hospitals and clinics segment across the overall vocal biomarkers market is poised to account for massive share driven by the rising product demand from these healthcare settings due to increasing footfall of patients. Rising patient admission in hospitals, given the prevalence of cardiovascular diseases like cardiac arrest, has been enunciating the demand for vocal biomarkers to detect the ailment. The product also supports healthcare staff to gauge the patient’s health status.
Geographically, North America vocal biomarker market would capture a commendable share of the overall market. This can be ascribed to the ongoing technological and healthcare advancements in the regional market. Additionally, mounting focus on national security and increasing healthcare expenditure would further augment the business space of market across the North American region.
Some of the prominent companies operating in the global vocal biomarkers market are Sonde Health Inc. (PureTech Health), Boston Technology Corporation, Beyond Verbal, Cogito Corporation, and Microtest Health amongst others. These players have been relentlessly working towards developing exceptional and effective vocal biomarkers to serve the thriving healthcare industry and gain a competitive edge in the global market. Meanwhile, the companies have also been engaged in strategic partnerships and collaborations to maintain a strong foothold in the overall market. For instance, Sonde Health had in March 2021, announced teaming up with Xavier University Center for Population Health to analyze the effectiveness of the former’s vocal biomarker platform as a screening tool for COVID-19 symptoms.
In yet another instance, Sonde Health recently declared collaborating with Qualcomm to develop a technology platform to help diagnose human health conditions from a short sample of speech.
The coronavirus pandemic outbreak has paved way for various research and developments in the medical industry. Development and research around vocal biomarkers to detect the symptoms of the SARS-CoV2 infection is set to have a positive impact on the global market through 2027.
Market, By Composition
Market, By Consumer
Market, By End-use,
The above information is provided for the following regions and countries: